Pharmacy Times will feature experts on kidney function assessment, IgG4-related disease, emerging CKD therapies, and gaps in cardiorenal care.
|Articles|August 19, 2016
Pharmacist Conviction in Black Market HIV Drug Scam Highlights Week in Specialty Pharmacy
Author(s)Davy James, Managing Editor
Top news of the week on Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/pharmacist-conviction-in-black-market-hiv-drug-sca" target="_blank">View the story "Pharmacist Conviction in Black Market HIV Drug Scam Highlights Week in Specialty Pharmacy" on Storify</a>]
Advertisement
Related to this article
In the phase 3 B-Well trials, about 1 in 5 adults reached functional cure after a fixed course, but a boxed warning makes monitoring key for pharmacists.
The once-daily device, bioequivalent to the existing prefilled syringe, gives adults with AChR antibody-positive generalized MG a second self-injection option.
A PharmD candidate reflects on the small, evidence-backed daily habits that helped her thrive—not just survive—through pharmacy school's most demanding years.
Understanding local health care priorities is essential to developing meaningful solutions.
Phase 2 DeLLphi-309 data show comparable activity in previously treated SCLC with less frequent dosing.
The most enduring resources a preceptor can give students are the confidence and tools to ask deeper questions.
A retrospective study of pharmacist-supported mirogabalin treatment highlights the need for careful evidence interpretation and sustained follow-up in cancer-related neuropathic pain.
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
CagriSema Tied to 25% Weight Loss in Women, Post Hoc Data Show
4
FDA Grants Accelerated Approval to Ravulizumab for Proteinuria Reduction in IgA Nephropathy
5